Reply to Teng et al. Comment on "Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. J. Clin. Med. 2024, 13, 3190"

Affiliations

¹ Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
² Department of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
³ Department of Obstetrics and Gynecology, Medical University of Warsaw, Pl. Starynkiewicza 1/3, 02-015 Warsaw, Poland.

Agnieszka Drozdowska-Szymczak et al. J Clin Med. 2024.

. 2024 Nov 22;13(23):7048.

doi: 10.3390/jcm13237048.

¹ Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
² Department of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
³ Department of Obstetrics and Gynecology, Medical University of Warsaw, Pl. Starynkiewicza 1/3, 02-015 Warsaw, Poland.

Abstract

We would like to express our sincere gratitude for your thoughtful review of our article [...].

The authors declare no conflict of interest.

1. Drozdowska-Szymczak A., Mazanowska N., Pomianek T., Ludwin A., Krajewski P. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024;13:3190. doi: 10.3390/jcm13113190. - DOI - PMC - PubMed
1. Teng J., Fischler B., Bohlin K., Reilly M., Tiblad E. Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190. J. Clin. Med. 2024;13:7047. doi: 10.3390/jcm13237047. - DOI - PMC - PubMed